Complement content in plasma under different storage conditions
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 12
Abstract
Objective To investigate the changes in complement content in component blood before blood transfusion. Methods 180 samples from 20 plasma donors were collected at different stages of the preparation process, stored at different temperatures and time periods, and tested in the same batch to observe the changes in complement C3 and C4 levels under different storage temperatures and process stages. Results The same sample was used to test C3 and C4 levels, and the test results were sorted into nine groups for comparison according to different storage temperatures and preparation process stages. C3: 0.994 1; C4: 0.957 1, with no significant difference in storage at -40℃ and -60℃(P>0.05); C3: 0.133 3, 0.224 06(P>0.05); C4: 0.027 3, 0.025 1(P<0.05), storing at 4℃ for 7 days may significantly reduce complement levels, which needs further verification; C3: 0.047 0, 0.038 3; C4: 0.042 6, 0.012 1(P<0.05), virus inactivation preparation process can significantly reduce complement levels, repeated freeze-thawing during frozen plasma processing can change complement levels. The correlation analysis of C3 and C4 content determination experiment shows that they are significantly positively correlated under different storage temperature, preparation process and storage time(P<0.05). Conclusion Storage temperature, storage time, preparation process of frozen plasma such as repeated freeze-thawing, centrifugal concentration and light inactivation have an impact on complement content.
Authors and Affiliations
Zhi HAN, Yujie HAN, Haihong ZHANG
Keywords
Related Articles
- EP ID EP738726
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.12.017
- Views 84
- Downloads 0
Safety evaluation of therapeutic plasma exchange in patients with lower hematocrit levels
[Objective] To retrospectively assess whether a lower hematocrit level (between 18% and 20%) had any impact on the safety of patients undergoing therapeutic plasma exchange (TPE), and to further determine the threshold f...
Research status and advances in immunotherapy for chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a malignant hematologic disorder caused by abnormal proliferation of hematopoietic stem cells. In recent years, while the application of tyrosine kinase inhibitors (TKIs) has significant...
Molecular mechanism of circRNA hsa_circ_0000290 regulating Zika virus replication: a preliminary study
Objective To investigate the effect of transfusion-transmitted Zika virus (ZIKV) on the expression of circular RNA (hsa_circ_0000290) and the role of hsa_circ_0000290 in ZIKV replication. Methods A549 or U251 cells were...
Characteristics of HBcrAg in HBsAg-/HBV DNA+ blood donors in Wuxi area
Objective To analyze the detection characteristics of a novel serum marker, hepatitis B core-associated antigen (HBcrAg), in the HBsAg-/HBV DNA+ blood donors in Wuxi. Methods A total of 37 previous HBsAg-/HBV DNA+ blood...
Therapeutic effect of chemoimmunotherapy on breast cancer sensitized by polymerized human cord hemoglobin in mice: a preliminary study
Objective To investigate the effect of polymerized human cord hemoglobin (PolyCHb) in chemoimmunotherapy for breast cancer in mice. Methods A 4T1 breast cancer in situ tumor model was established, and 15 mice were random...